Y-Intercept (HK)’s Pharvaris PHVS Stock Holding History

Y-Intercept (HK)’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$436K	Sell	13,738 -26,196	-66%	-$917K	0.01%	1327
2026 Q2	$1.38M	Buy	+39,934	New	+$1.21M	0.03%	895
2024 Q3	–	Sell	-15,883	Closed	-$299K	–	1687
2024 Q2	$299K	Buy	+15,883	New	+$323K	0.02%	1034
2023 Q4	–	Sell	-17,553	Closed	-$366K	–	1561
2023 Q3	$366K	Buy	+17,553	New	+$324K	0.04%	681

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Y-Intercept (HK)'s PHVS Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Pharvaris (PHVS) stake by 66% in Q3 2026, selling an estimated $917K and leaving 13,738 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #1327.

Y-Intercept (HK) first reported a position in PHVS in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.38M in Q2 2026. 30 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.

Y-Intercept (HK) held 13,738 shares of Pharvaris worth $436K as of Q3 2026.
Y-Intercept (HK) sold 26,196 Pharvaris shares in Q3 2026, an estimated $917K.
Pharvaris made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1327 holding.
Y-Intercept (HK) first reported a position in Pharvaris in Q3 2023 and has held it in 4 quarters since.
Y-Intercept (HK)'s Pharvaris position peaked at $1.38M in Q2 2026.
30 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.